NVCR CIK: 1645113

NovoCure Ltd

  • Switzerland
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
82.8
FY22:
30.8
FY23:
−73.3
FY24:
−26.4
FY25:
−49.0
Change from FY21 to FY25
millions USD
FY21:
−145
FY22:
−140
FY23:
184
FY24:
−140
FY25:
437
Change from FY21 to FY25
millions USD
FY21:
25.7
FY22:
15.5
FY23:
15.8
FY24:
90.3
FY25:
−451
millions USD
FY21:
−36.6
FY22:
−93.8
FY23:
127
FY24:
−76.5
FY25:
−62.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
58.6
FY22:
9.43
FY23:
−100
FY24:
−69.2
FY25:
−75.7

All amounts in millions USD Data source:SEC EDGAR